Location History:
- Copenhagen, DK (2003)
- Charlottenlund, DK (2015 - 2019)
Company Filing History:
Years Active: 2003-2019
Title: Jacob Sten Petersen: Innovator in Insulin Analogues
Introduction
Jacob Sten Petersen is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of insulin analogues. With a total of 3 patents, his work has the potential to impact diabetes treatment significantly.
Latest Patents
Petersen's latest patents include innovative formulations of protease-stabilized acylated insulin analogues. These novel acylated insulin analogues exhibit resistance towards proteases, allowing for effective administration via pulmonary or oral routes. The insulin analogues contain specific modifications, including B25H and either A14E or A14H, enhancing their stability and efficacy.
Career Highlights
Throughout his career, Jacob Sten Petersen has worked with prominent organizations such as Novo Nordisk A/S and The Penn State Research Foundation. His experience in these institutions has allowed him to refine his research and contribute to advancements in diabetes management.
Collaborations
Petersen has collaborated with esteemed colleagues, including Peter Madsen and Thomas Boerglum Kjeldsen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jacob Sten Petersen's work in developing acylated insulin analogues represents a significant advancement in diabetes treatment. His innovative approach and collaborations with leading professionals in the field highlight his commitment to improving patient care.